Confidentiality and trial integrity issues for monitoring adaptive design trials Paul Gallo FDA-Industry Workshop September 28, 2006.
09/12/2008AD course for Philadelphia ASA Chapter Introduction to Adaptive Designs: Definitions and Classification Inna Perevozskaya, Merck & Co.
Adaptive Designs Working Group Adaptive Designs Logistic, Operational and Regulatory Issues Judith Quinlan Biopharm Statistics Leader Drug Discovery Sciences.
Confidentiality and trial integrity issues for monitoring adaptive design trials
